M. DAVID MACFARLANE SEC EDGAR Filings (CIK 0001182314)

SEC EDGAR filings, ownership reports, and insider transactions for M. DAVID MACFARLANE.

Business address
C/O Titan Pharmaceuticals Inc, 400 Oyster Point Blvd, S San Francisco, CA, 94080
Get insider transactions for this reporting owner
M. DAVID MACFARLANE has filed 18 SEC EDGAR filings since 02 Sep 2004

Latest Filings

Recent SEC filings for M. DAVID MACFARLANE including 4, 3, 4/A.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 05 Jan 2022 05 Jan 2022 001-13341
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 11 Feb 2021 10 Feb 2021 001-13341
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 25 Sep 2018 21 Sep 2018 001-13341
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 19 Sep 2017 15 Sep 2017 001-13341
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 21 Feb 2017 16 Feb 2017 001-13341
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 16 Dec 2015 14 Dec 2015 001-13341
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 18 Mar 2015 16 Mar 2015 000-27436
4 Open 4 document View SEC filing for 4 FORM 4 14 Feb 2014 12 Feb 2014 000-27436
4 Open 4 document View SEC filing for 4 MAIN DOCUMENT DESCRIPTION 05 Jan 2012 03 Jan 2012 000-27436
4 Open 4 document View SEC filing for 4 FORM 4 19 Apr 2011 15 Apr 2011 000-27436
3 Open 3 document View SEC filing for 3 FORM 3 15 Mar 2010 15 Mar 2010 000-27436

About this filer

M. DAVID MACFARLANE files with the SEC under CIK 0001182314. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages